From our private database of 26,900+ case briefs...
The Medicines Company v. Hospira, Inc.
United States Court of Appeals for the Federal Circuit
827 F.3d 1363, 119 U.S.P.Q.2d 1329 (Fed.Cir.2016) (en banc)
The Medicines Company (MedCo) (plaintiff) was a pharmaceutical company that marketed a drug named Angiomax, the trade name of a form of bivalirudin. MedCo contracted with Ben Venue Laboratories to manufacture Angiomax. Ben Venue completed the first batch of Angiomax on October 31, 2006. Ben Venue completed two more batches in late 2006. The three batches had a combined market value of well over $20 million. MedCo paid Ben Venue approximately $350,000 to manufacture the batches. Each invoice stated: “Charge to manufacture Bivalirudin lot.” MedCo was granted two patents covering an improved form of Angiomax. The patents were filed on July 27, 2008. MedCo made Angiomax available for sale in August 2007. Hospira, Inc. (defendant) sought approval to sell generic bivalirudin before the expiration of MedCo’s patents. Hospira argued that by manufacturing the patented product for MedCo, Ben Venue put the invention on sale. Thus, Hospira argued, the on-sale bar of 35 U.S.C. § 102(b) was triggered and MedCo was barred from patenting the later version of Angiomax. Hospira also argued that finding the bar inapplicable here would improperly permit an inventor to stockpile his invention. Additionally, Hospira argued that a number of similar cases applied to the on-sale bar. The trial court ruled that the transactions between Ben Venue and MedCo did not trigger the on-sale bar. Hospira appealed.
Rule of Law
Holding and Reasoning (O’Malley, J.)
What to do next…
Unlock this case brief with a free (no-commitment) trial membership of Quimbee.
You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 541,000 law students since 2011. Some law schools—such as Yale, Berkeley, and Northwestern—even subscribe directly to Quimbee for all their law students.Unlock this case briefRead our student testimonials
Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.
Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students.Learn about our approachRead more about Quimbee
Here's why 541,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 26,900 briefs, keyed to 983 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.